Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4378891 | 0.85 | MEN1 (0.76) | MEN1KMT2ACA2ALDH1A1TSHR | |
| SCHEMBL7203378 | 0.81 | MEN1 (0.70) | MEN1KMT2ACA2ALDH1A1L3MBTL1 | |
| SCHEMBL16047001 | 0.81 | MEN1 (0.70) | MEN1KMT2ACA2ALDH1A1L3MBTL1 | |
| SCHEMBL2817045 | 0.81 | CA1 (0.48) | CA2CA1CA9ALDH1A1TSHR | |
| SCHEMBL389123 | 0.79 | TSHR (0.61) | MEN1KMT2ACA2ALDH1A1TSHR | |
| SCHEMBL38661849 | 0.79 | MEN1 (0.68) | MEN1KMT2ACA2ALDH1A1L3MBTL1 | |
| SCHEMBL17333323 | 0.79 | CA1 (0.47) | CA2CA1CA9ALDH1A1TSHR | |
| SCHEMBL28104834 | 0.78 | TSHR (0.59) | MEN1KMT2ACA2ALDH1A1TSHR | |
| SCHEMBL3366798 | 0.78 | CA1 (0.46) | CA2CA1CA9ALDH1A1TSHR | |
| SCHEMBL516899 | 0.78 | TSHR (0.53) | CA2CA1CA9TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7645851-B2 | Polycarbonate with reduced color | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-01-12 | — | — | US | claimed |
| EP-2035500-A2 | POLYCARBONATE WITH REDUCED COLOR | Sabic Innovative Plastics IP B.V. (NL) | 2009-03-18 | — | — | EP | claimed |
| WO-2008005655-A2 | POLYCARBONATE WITH REDUCED COLOR | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-01-10 | — | — | WO | claimed |
| US-20080004379-A1 | Polycarbonate with Reduced Color | GENERAL ELECTRIC COMPANY (US) | 2008-01-03 | — | — | US | claimed |
| US-20240300055-A1 | METAL PASTE FOR JOINING, JOINT, AND MANUFACTURING METHOD THEREFOR | RESONAC CORPORATION (JP) | 2024-09-12 | — | — | US | disclosed |
| EP-4368317-A1 | METAL PASTE FOR JOINING, JOINT, AND MANUFACTURING METHOD THEREFOR | Resonac Corporation (JP) | 2024-05-15 | — | — | EP | disclosed |
| CN-117916038-A | Metal paste for bonding, bonded body, and method for producing same | 株式会社力森诺科 | 2024-04-19 | — | — | CN | disclosed |
| CN-113372383-B | Preparation method of organic phosphate compound | 中南大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-113372383-A | Preparation method of organic phosphate compound | 中南大学 | 2021-09-10 | — | — | CN | disclosed |
| US-8962788-B2 | Production of a polycarbonate with limited metal residuals | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-02-24 | — | — | US | disclosed |
| WO-2014141108-A1 | PRODUCTION OF A POLYCARBONATE WITH LIMITED METAL RESIDUALS | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2014-09-18 | — | — | WO | disclosed |
| US-20140275466-A1 | PRODUCTION OF A POLYCARBONATE WITH LIMITED METAL RESIDUALS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2014-09-18 | — | — | US | disclosed |
| US-7645851-B2 | Polycarbonate with reduced color | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-01-12 | — | — | US | disclosed |
| US-7541420-B2 | Method for making molded polycarbonate articles with improved color | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2009-06-02 | — | — | US | disclosed |
| EP-2041202-A1 | METHOD FOR MAKING MOLDED POLYCARBONATE ARTICLES WITH IMPROVED COLOR | Sabic Innovative Plastics IP B.V. (NL) | 2009-04-01 | — | — | EP | disclosed |
| EP-2035500-A2 | POLYCARBONATE WITH REDUCED COLOR | Sabic Innovative Plastics IP B.V. (NL) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008005633-A1 | METHOD FOR MAKING MOLDED POLYCARBONATE ARTICLES WITH IMPROVED COLOR | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-01-10 | — | — | WO | disclosed |
| WO-2008005655-A2 | POLYCARBONATE WITH REDUCED COLOR | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-01-10 | — | — | WO | disclosed |
| US-20080004379-A1 | Polycarbonate with Reduced Color | GENERAL ELECTRIC COMPANY (US) | 2008-01-03 | — | — | US | disclosed |
| US-20080004407-A1 | Molding polycarbonate resin made by a transesterification reaction using an activated diaryl carbonate such that the polycarbonate is susceptible to formation of internal ester linkages (IEL), and controlling (IEL) through incorporation of phosphite additive that inhibits the linkages | GENERAL ELECTRIC COMPANY (US) | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140275466-A1 | PRODUCTION OF A POLYCARBONATE WITH LIMITED METAL RESIDUALS | BMI1, EZH2, SUV39H2 | MEN1 262/4885KMT2A 186/4885CA2 928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.